Skip to main content

Clinical trial BHS-TC11-01

A Phase II study to assess the safety and the efficacy of extracorporeal photopheresis using the Theraflex ECPTM (Macropharma) for patients with refractory chronic GVHD

Organ NA
Trial status Trial open for recruitment
Trial type
Interventional without experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor BHS
BECT Identifier B079201318627
Inclusion criteria chronic GVHD - already been treated with first-line systemic therapy for at least 1 month - refractoriness or contraindication/intolerance to current therapy
Last update